175 related articles for article (PubMed ID: 37942297)
1. Association Between Hypnotic Use and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease and Insomnia.
El-Solh AA; Lawson Y; Wilding GE
Int J Chron Obstruct Pulmon Dis; 2023; 18():2393-2404. PubMed ID: 37942297
[TBL] [Abstract][Full Text] [Related]
2. Risks of Zolpidem among Patients with Chronic Obstructive Pulmonary Disease.
Castaneda JM; Hee Wai T; Spece LJ; Duan KI; Leonhard A; Griffith MF; Plumley R; Palen BN; Feemster LC; Au DH; Donovan LM
Ann Am Thorac Soc; 2024 Jan; 21(1):68-75. PubMed ID: 37916873
[No Abstract] [Full Text] [Related]
3. Insomnia Diagnosis, Prescribed Hypnotic Medication Use, and Risk for Serious Fall Injuries in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
Thomas SJ; Sakhuja S; Colantonio LD; Li M; Muntner P; Reynolds K; Bowling CB
Sleep; 2022 May; 45(5):. PubMed ID: 35554593
[TBL] [Abstract][Full Text] [Related]
4. Hypnotic use for insomnia management in chronic obstructive pulmonary disease.
Roth T
Sleep Med; 2009 Jan; 10(1):19-25. PubMed ID: 18693067
[TBL] [Abstract][Full Text] [Related]
5. Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study.
Ray WA; Chung CP; Murray KT; Malow BA; Daugherty JR; Stein CM
PLoS Med; 2021 Jul; 18(7):e1003709. PubMed ID: 34264928
[TBL] [Abstract][Full Text] [Related]
6. The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study.
Chen SJ; Yeh CM; Chao TF; Liu CJ; Wang KL; Chen TJ; Chou P; Wang FD
Sleep; 2015 Jul; 38(7):1045-50. PubMed ID: 25669186
[TBL] [Abstract][Full Text] [Related]
7. Sex- and age-specific all-cause mortality in insomnia with hypnotics: Findings from Japan multi-institutional Collaborative Cohort Study.
Sogawa R; Shimanoe C; Tanaka K; Hara M; Nishida Y; Furukawa T; Nagayoshi M; Hishida A; Kubo Y; Kato Y; Oze I; Ito H; Nakamura Y; Kusakabe M; Tanoue S; Koriyama C; Suzuki S; Otani T; Matsui D; Watanabe I; Kuriki K; Takashima N; Kadota A; Watanabe T; Arisawa K; Ikezaki H; Otonari J; Wakai K; Matsuo K;
Sleep Med; 2022 Dec; 100():410-418. PubMed ID: 36240602
[TBL] [Abstract][Full Text] [Related]
8. Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease.
Le TT; Park S; Choi M; Wijesinha M; Khokhar B; Simoni-Wastila L
BMJ Open Respir Res; 2020 Mar; 7(1):. PubMed ID: 32213535
[TBL] [Abstract][Full Text] [Related]
9. The risk of major adverse cardiovascular events associated with the use of hypnotics in patients with insomnia.
El-Solh AA; Lawson Y; Wilding GE
Sleep Health; 2023 Oct; 9(5):717-725. PubMed ID: 37393143
[TBL] [Abstract][Full Text] [Related]
10. Non-Benzodiazepine Receptor Agonists for Insomnia.
Becker PM; Somiah M
Sleep Med Clin; 2015 Mar; 10(1):57-76. PubMed ID: 26055674
[TBL] [Abstract][Full Text] [Related]
11. Patterns of hypnotic prescribing for residual insomnia and recurrence of major depressive disorder: a retrospective cohort study using a Japanese health insurance claims database.
Yamato K; Inada K; Enomoto M; Marumoto T; Takeshima M; Mishima K
BMC Psychiatry; 2021 Jan; 21(1):40. PubMed ID: 33441086
[TBL] [Abstract][Full Text] [Related]
12. Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs.
Luyster FS; Boudreaux-Kelly MY; Bon JM
Respir Res; 2023 Mar; 24(1):93. PubMed ID: 36964552
[TBL] [Abstract][Full Text] [Related]
13. Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.
Chung KH; Li CY; Kuo SY; Sithole T; Liu WW; Chung MH
J Clin Sleep Med; 2015 Apr; 11(5):543-51. PubMed ID: 25766696
[TBL] [Abstract][Full Text] [Related]
14. [Present status and future of hypnotic drug treatment for insomnia].
Uchiyama M; Konno M
Nihon Rinsho; 2012 Jul; 70(7):1241-51. PubMed ID: 22844812
[TBL] [Abstract][Full Text] [Related]
15. Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample.
Scalo J; Desai P; Rascati K
Qual Life Res; 2015 May; 24(5):1223-33. PubMed ID: 25432884
[TBL] [Abstract][Full Text] [Related]
16. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with long-term use of hypnotics among patients with chronic insomnia.
Takaesu Y; Komada Y; Asaoka S; Kagimura T; Inoue Y
PLoS One; 2014; 9(11):e113753. PubMed ID: 25409018
[TBL] [Abstract][Full Text] [Related]
18. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.
Morgan K; Dixon S; Mathers N; Thompson J; Tomeny M
Health Technol Assess; 2004 Feb; 8(8):iii-iv, 1-68. PubMed ID: 14960254
[TBL] [Abstract][Full Text] [Related]
19. Reducing hypnotic use in insomnia management among Australian veterans: results from repeated national interventions.
Kalisch Ellett LM; Lim R; Pratt NL; Kerr M; Ramsay EN; LeBlanc TV; Barratt JD; Roughead EE
BMC Health Serv Res; 2018 Aug; 18(1):626. PubMed ID: 30092801
[TBL] [Abstract][Full Text] [Related]
20. The association between various characteristics of hypnotics and cardiac autonomic control in community-dwelling older adults: the Yilan Study, Taiwan.
Tang IT; Hsu NW; Chou P; Chen HC
Sleep Med; 2020 Jul; 71():77-82. PubMed ID: 32502853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
